To create investment opportunities in life science and femtech companies through Portfolia Inc.
To serve on Boards of Directors and to train and promote well educated board members, through BoardWise and BoardFutures
Since 1983 Science Futures focused on supporting the investment and creation of world class life science companies. Consulting with premier venture capital firms, like Kleiner Perkins Caulfield and Byers, Oak Investment Partners, Mohr Davidow, IVP, Fairfield Ventures and TVM Capital. Science Futures prepared analysis of business proposals and wrote initial business plans which lead to Series A investment made by the large funds and eventually became publically listed companies with market capitalizations that at some point were or still are greater than roughly one billion dollars: Idec Pharmaceutical (BiogenIDEC) InSight Vision, Resound, Sequenom, Alkemes.
Consulting with Drexel Burnham Lambert, and Merrill Lynch, Science Futures was the initial voice of biotechnology on Wall Street. Consulting on IPO’s and follows- on investments help build the industry and reward the initial investors. De-mystifying the biotech revolution for public investors was an important part of the company’s initial work. Other early clients included oil companies and early biotechnology management teams.
Science Futures started to directly invest in funds in 1998 by raising a fund of funds for TVM Medical Ventures. Investing directly into TVM 4 and TVM 5 as a venture partner and remained as a senior advisor in the firm until the late 2000’s.
Science Futures continues to invest through Portfolia Investment Funds, designed for women backing innovative companies for returns and impact